allogeneic virus-specific T lymphocytes

A preparation of allogeneic donor-derived T lymphocytes that are specifically reactive to adenovirus (AdV), cytomegalovirus (CMV), Epstein-Barr virus (EBV) and human polyomavirus type I (BKV), with potential antiviral activity. Upon administration, allogeneic VSTs may kill AdV, CMV, EBV and/or BKV-infected cells, thereby preventing or reducing the severity of viral infections by these pathogens.